Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years

Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting

NCT00787566 ·Status: COMPLETED ·Phase: PHASE2

Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents

NCT04472143 ·Status: UNKNOWN ·Phase: PHASE2

A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting

NCT01937156 ·Status: COMPLETED ·Phase: PHASE3

Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy

NCT00359567 ·Status: COMPLETED ·Phase: PHASE3

Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation

NCT01536392 ·Status: COMPLETED ·Phase: PHASE3

Granisetron Transdermal Patch System for Prevention of CINV by CapeOX

NCT05325190 ·Status: UNKNOWN ·Phase: PHASE2

BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron

NCT04150614 ·Status: RECRUITING ·Phase: PHASE4

ONO-7436 Phase II Study in Japan

NCT00212602 ·Status: COMPLETED ·Phase: PHASE2

Phase II Study of SyB D-0701 for Radiotherapy-Induced Nausea and Vomiting (RINV)

NCT01700140 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy

NCT07130617 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting

NCT00503386 ·Status: COMPLETED ·Phase: PHASE2

Phamacokinetic and Pharmacodynamic Study of Ramosetron in Chemotherapy Induced Nasea and Vomiting

NCT02076529 ·Status: COMPLETED ·Phase: NA

Safety Study of Repeat Doses of SUSTOL in Adults

NCT05434663 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease

NCT00005024 ·Status: UNKNOWN ·Phase: PHASE3

Nausea and Vomiting in Children Receiving Chemotherapeautic Monotherapy

NCT01661413 ·Status: COMPLETED

An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients

NCT00666783 ·Status: COMPLETED ·Phase: PHASE2

An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects

NCT00954291 ·Status: UNKNOWN

Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients

NCT01442376 ·Status: COMPLETED ·Phase: PHASE3

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

NCT07217600 ·Status: RECRUITING ·Phase: PHASE4

Lerisetron Compared With Granisetron in Preventing Nausea and Vomiting in Men Being Treated With Radiation Therapy for Stage I Seminoma

NCT00004219 ·Status: UNKNOWN ·Phase: PHASE3

Nano-crystalline Megestrol Acetate for Chemotherapy-induced Nausea and Vomiting

NCT07246070 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)

NCT00818259 ·Status: TERMINATED ·Phase: PHASE1

A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)

NCT01054456 ·Status: COMPLETED ·Phase: PHASE2

Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting

NCT04085393 ·Status: WITHDRAWN ·Phase: PHASE2

Granisetron Transdermal Patch for Prophylaxis of Delayed CINV

NCT04912271 ·Status: UNKNOWN ·Phase: PHASE3